Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2013

Pas Suzan D, Streefkerk Roel H R A, Pronk Mark, de Man Robert A, Beersma Matthias F, Osterhaus Albert D M E, van der Eijk Annemiek A

Abstract excerpt

BACKGROUND: Hepatitis E virus (HEV) genotype 3 is recognised as an emerging pathogen in industrialised countries. The currently commercially available HEV-specific enzyme linked immunosorbent assays (ELISAs) are primarily designed for the detection of antibodies against genotypes 1 (Burma) and 2 (Mexico) and may not sensitively detect HEV genotypes 3 or 4. OBJECTIVES: This study aimed to evaluate the analytical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Enzyme-Linked Immunosorbent Assay
Share to Hepatitis Antibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis E

Share to Hepatitis E virus

Share to Immunocompromised Host

Share to Immunoglobulin G

Share to Immunoglobulin M

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 24210958
DOI: 10.1016/j.jcv.2013.10.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.PMID 24210958Read ↗

Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.Semantic proximity Read ↗

Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection.Semantic proximity Read ↗

Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.Semantic proximity Read ↗

An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population.Semantic proximity Read ↗

Laboratory challenges in the diagnosis of hepatitis E virus.Semantic proximity Read ↗

Good Performance of Immunoglobulin M Assays in Diagnosing Genotype 3 Hepatitis E Virus InfectionsSemantic proximity Read ↗

Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.Semantic proximity Read ↗

Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.Semantic proximity Read ↗

Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.Semantic proximity Read ↗

Development of a competitive ELISA for detecting antibodies against genotype 1 hepatitis E virus.Semantic proximity Read ↗

Hepatitis E virus infection in the Irish blood donor population.Semantic proximity Read ↗

Hepatitis E virus antibody prevalence, RNA frequency, and genotype among blood donors in Cambodia (Southeast Asia).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.